Connect with us
deals book
Advertisement
Polaris bank
Advertisement
Oando
Advertisement
Alpha
Advertisement
Hotflex
Advertisement
Binance
Advertisement
Advertisement
UBA
Advertisement
Patricia
Advertisement
Access bank
Advertisement
app

Business News

Morison Industries Plc appoints Deji Mustapha as Acting MD

Deji Mustapha’s appointed Morison boss

Published

on

Corporate Actions, NSE

The Board and Management of Morison Industries Plc, have approved the appointment of Deji Mustapha as its Acting Managing Director (MD) with effect from December 10, 2018.

Mustapha’s appointment follows the resignation of Nwabueze Oputa as the company’s MD, which took effect from November 30, 2018.

Morison Industries made these disclosures in a notification to the Nigerian Stock Exchange (NSE) and Shareholders of the company.

What you should know about Deji Mustapha

Deji Mustapha is best described as an accomplished leader with wide multidisciplinary exposures and successful track records at tactical and strategic levels of financial and general management. Deji has a clear vision of making landmark contribution in leadership and corporate governance.

Deji started his professional training career in 1984 with Messrs. Akintola William & Co. (now Deloitte), where the foundation for his varied experiences in the areas of audit, investigation, accounting, taxation, company secretariat practice as well as management consultancy were laid.

His working experience has also seen him through Pivot Engineering Company Limited as Chief Finance Officer where he wasin charge of Policies Formulation and Implementation. He had a stint at General Manager-level position with Christaben Group, a mid and downstream investment company in the oil and gas sector, where he coordinated and supervised the group’s commercial and investment activities.

He comes as one of the best managers of the media business in Nigeria, as Group Executive Director/Managing Director at Leaders & Company Ltd, publishers of ThisDay Newspapers, between the year 2000 and 2010 where he brought his rich corporate experience in accounting, finance, administration, construction and leadership to bear.

Deji has a sharp analytical mind and he is very meticulous in his work. Several innovations introduced by him while at THISDAY remain eloquent testimonies of his diligence, dedication and discipline as a chartered accountant. He later joined the services of Timbuktu Media Limited (Publishers of 234 NEXT Newspapers), as Senior Executive Vice President of the Company.

Most recently since 2012, he has been a Partner at Doyin Owolabi & Co, Chartered Accountants, where he continued his services in audit, investigation, accounting, taxation, company secretariat practice as well as management consultancy for public liability companies and MDAs of State/Federal Governments.

Deji is also endowed with exposures to international best practices in consultancy and project management through international workshops and benchmarking over the past thirty fourthirty-four. He is an alumnus of The Global Institute for Leadership Development, USA (GILD 2008- 2009), Leading Diversity Summit, USA (2007), Fellow of the Institute of Chartered Accountants of Nigeria (1997), as well as holding an MBAin Financial Management from the University of Lagos (1991), and B.Sc. with Second Class Upper in Accounting from the University of Basin (1983).

About Morison

Morison Industries Plc manufactures and distributes excellent quality hygiene and health care products. Morison Industries Plc is a public limited company quoted on the NSE under the Healthcare Sector. The company became a public quoted company in 1978 when it became listed on the NSE.

Morison Industries Plc traded N0.55 on the floor of the NSE on Tuesday, December 18, 2018.

Famuyiwa Damilare is a trained journalist. He holds a Higher National Diploma (HND) in Mass Communication at the prestigious Nigerian Institute of Journalism (NIJ).Damilare is an innovative and transformational leader with broad-based expertise in journalism and media practice at large. He has explored his proven ability in the areas of reporting, curating and generating contents, creatively establishing social media engagements, and mobile editing of videos. It is safe to say he’s a multimedia journalist.

Click to comment

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Coronavirus

Covid-19: WHO approves China’s Sinopharm vaccine

WHO has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination.

Published

on

Covid-19: First world nations oppose waiving intellectual rights for vaccine development

The World Health Organization (WHO) has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination.  The vaccine is reported to have 79% efficacy against covid.

This was disclosed today in a report by Reuters. The vaccine would also be the second Chinese-made vaccine after Sinovac vaccine and would be the first developed outside Europe and North America to receive WHO accreditation.

“This expands the list of COVID-19 vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,” WHO Director-General, Tedros Adhanom Ghebreyesus said.

The WHO added that the easy storage requirements make it highly suitable for low-resource settings.

“Its easy storage requirements make it highly suitable for low-resource settings,” a WHO statement said while also disclosing that the vaccine has been approved for people above the age of 18 to receive two shots.

“On the basis of all available evidence, WHO recommends the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks,” the statement added.

The vaccine was created by Beijing Biological Products Institute, a subsidiary of Sinopharm subsidiary China National Biotec Group, with an efficacy of 79% for all age groups.

The WHO however, admitted that few older adults (over 60 years) were enrolled in clinical trials, so efficacy could not be estimated in this age group.

Hotflex

In case you missed it

The quest for vaccine efficiency got a major boost earlier this week as Nairametrics reported that the United States government announced that it supports the waiver of Intellectual Property Protections on Covid-19 vaccine development, in a bid to boost the fight against the pandemic, and says it will participate in the Okonjo-Iweala-led WTO negotiation to make it happen.

Continue Reading

Obituaries

“Mama Taraba”, Former minister and senator, Aisha Al-Hassan is dead

Ex-Women Affairs minister, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead

Published

on

A former Minister for Women Affairs and ex-Governorship Candidate in Taraba State, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead.

According to media reports she died in a hospital on Friday in Cairo, Egypt at the age of 61.

Al-Hassan, who was a former senator of the Federal Republic of Nigeria from Taraba North Senatorial District, was the All Progressive Congress (APC) Governorship Candidate for Taraba in the 2015 general elections.

READ: Abba Kyari’s last letter to President Buhari

She later contested for the same seat on the platform of the United Democratic Party in the 2019 general elections after resigning from APC and as a minister in the administration of President Muhammadu Buhari on July 27, 2018.

The former senator was born on the 16th of September, 1959 in Jalingo, Taraba State, to Alhaji Abubakar Ibrahim, Sarkin Ayukan Muri.

READ: Chad’s President Deby dies of injuries suffered on the frontlines, as son takes over

Aisha Jummai Al-Hassan attended Muhammed Nya Primary School, Jalingo and LEA Primary School, Tudun Wada, Kaduna before proceeding to Saint Faith College (now GGSS) Kawo Kaduna where she studied between January 1973 and June 1977.

Hotflex

Details later…

Continue Reading

  





Nairametrics | Company Earnings

Access our Live Feed portal for the latest company earnings as they drop.